PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding PDS Biotechnology Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 55 | 1 | 47 | −7 |
| Shares | 7.45M | 13.4K | 5.62M | −1.82M (−24.4%) |
| Value | $9.90M | $18.0K | $5.32M | −$4.56M (−46.1%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held PDS Biotechnology Corp at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Amussen Hunsaker Associates LLC | 75,016 | $76.5K | 0.01% |
| Acadian Asset Management LLC | 61,793 | $61.0K | 0.00% |
| Rockefeller Capital Management L.P. | 34,467 | $34.8K | 0.00% |
| XTX Topco Ltd | 19,699 | $19.9K | 0.00% |
| Simplex Trading, LLC | 12,405 | $12.0K | 0.00% |
| Baader Bank INC | 10,528 | $6.57K | 0.00% |
| Jones Financial Companies LLLP | 2,000 | $2.04K | 0.00% |
| Citigroup Inc | 24 | $24 | 0.00% |
Sold out (15)
Institutions that held PDS Biotechnology Corp at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Armistice Capital, LLC | 2,236,000 | $2.97M |
| Millennium Management LLC | 81,449 | $108.3K |
| Marshall Wace, LLP | 68,454 | $91.0K |
| Virtu Financial LLC | 32,002 | $43.0K |
| Price T Rowe Associates Inc | 24,263 | $33.0K |
| Marex Group plc | 14,000 | $18.6K |
| JustInvest LLC | 13,979 | $18.6K |
| Sandbox Financial Partners, LLC | 12,666 | $16.8K |
| Cubist Systematic Strategies, LLC | 10,861 | $14.4K |
| Ronald Blue Trust, Inc. | 4,500 | $5.99K |
| Tower Research Capital LLC (TRC) | 2,002 | $2.66K |
| Rise Advisors, LLC | 840 | $1.12K |
| Point72 (DIFC) Ltd | 50 | $66 |
| National Bank of Canada | 1 | $1 |
| Caitong International Asset Management Co., Ltd | 1 | $1 |
Not filed for Q3 2025 yet (1)
Institutions that held PDS Biotechnology Corp at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Wealth Group, Ltd. | 13,399 | $18.0K |